AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05179876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan
Description: Adult participants will receive oral dose of macitentan 10 milligrams (mg) tablet once daily. Children greater than or equal to (>=) 2 year to less than (\<) 18 years will be given an oral macitentan dose tailored to their body weight, ensuring an equivalent level of systemic exposure as in adults.
Study NCT05179876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selexipag
Description: Participant will receive oral dose of selexipag tablet twice daily at the dose strength corresponding to their maintenance dose at the end of their parent study. Available strengths: 200, 400, 600, 800, 1000, 1200, 1400 and 1600 micrograms.
Study NCT05179876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan/Tadalafil FDC
Description: Participants will receive oral FDC of macitentan 10 mg and tadalafil 40 mg once daily during the course of the study as already received in the parent studies.
Study NCT06470438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-88998377
Description: JNJ-88998377 will be administered.
Study NCT06324019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: putting on an examination gown
Description: During the gynecological examination, the patient in the experimental group will be made to wear an examination gown, while the patient in the control group will use the routine practice of the hospital. In this way, with the gynecological examination clothing to be developed, the body privacy of the patients will be protected during the examination. In addition, women will feel less anxiety during gynecological examination and important steps will be taken in maintaining women\&#39;s health by ensuring regular gynecological examination.
Study NCT04575363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample
Study NCT04941157 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cerebrospinal Fluid Drain Placement
Description: Prophylactic CSF Spinal Drain to be placed prior to surgery in patients randomized to the experimental arm of the study
Study NCT06254898 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Child life standard of care
Description: Standard preparation and support provided to the participant by a Certified Child Life Specialist.
Study NCT06254898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Child life standard of care + incentives provided with conditional agreement.
Description: Patient is provided standard preparation and support provided to the participant by a Certified Child Life Specialist. Before the procedure the child life specialist discusses earning a prize with the patient if they demonstrate the agreed upon coping goal (i.e. holding arm still, taking deep breaths, engaging in distraction.) At the end of the procedure the patient is provided with the prize if they earn the prize based on the agreed upon coping plan.
Study NCT06254898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Child life standard of care + incentive provided unconditionally.
Description: Patient is provided standard preparation and support provided to the participant by a Certified Child Life Specialist. After the procedure is complete the patient is provided with a prize. The patient does not need to do anything to earn the prize.
Study NCT05388058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Description: Applied topically
Study NCT05388058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Administration
Description: Applied topically
Study NCT05388058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05388058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05687916 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: TAK-861 placebo matching tablets.
Study NCT05687916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-861 2 mg
Description: TAK-861 2 mg tablets.
Study NCT05687916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-861 2 mg and 5 mg
Description: TAK-861 2 mg and 5 mg tablets.
Study NCT05443737 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-component oncofertility care intervention
Description: The multi-component oncofertility care intervention includes: (1) an adaptive and smart default electronic health record-based oncofertility needs screen and referral pathway, (2) telehealth oncofertility counseling as indicated, and (3) telehealth oncofertility financial navigation as indicated.
Study NCT05425992 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Patient/parent dyads expressing interest will be interviewed by a bilingual Spanish certified provider via televideo with as needed interpreter support. Interviews will be audio recorded for review and translation purposes and then will be destroyed. Interview format will be supportive and information seeking only with reassurance that purpose is for care improvement and that all answers will be evaluated without association to patient name. Interviews will then be translated and reviewed by the PI for themes regarding perceived clinic successes and perceived clinic barriers in communication or care.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Driving Tips
Description: Each week participants will receive a safe driving tip for one of the four behaviors via text message.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Feedback
Description: Each week participants will receive a text message showing their overall driving score (out of 100) and subscores for distraction, hard braking, fast acceleration, and speeding (all running averages). The scoreboard will indicate whether their scores have gone up, down, or stayed the same. The message will include a link to a dashboard.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Assigned Focus Area Feedback
Description: Each week feedback will focus the participant's attention on the driving behavior with the greatest opportunity for improvement based on their baseline driving behavior. Participants will be assigned a goal for the week of a score 5 points (3 points in the case of Driver Focus) better than their baseline for that area. If they meet the goal, they will be given a new goal 5 points higher; if they fall short, they will be asked to try for the same goal again. If they improve sufficiently-or if their improvement stalls out-they will be assigned a new behavior to focus on.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Study Dashboard (Standard)
Description: By clicking the link in the feedback text, they will be able to view a weekly dashboard that provides detailed information about their baseline, best, last, and average scores for each of the four behaviors, plus descriptions of the four behaviors.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Study Dashboard (focused)
Description: Same as standard study dashboard, except participants will see at the top of the dashboard how well they are doing relative to their weekly goals.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: UBI-like Behavioral Incentive
Description: At the end of the 12-week intervention period, their overall driving score will be translated into a $0-$100 reward amount. For example, a participant with an overall driving score of 84 at the end of the intervention period would receive $84 in compensation.
Study NCT06101251 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sef-Chosen Focus Area Feedback
Description: Participants will be asked to select which driving behavior they want to focus on improving, and to set a goal for the week that is above their baseline score. If they meet the goal, they will be asked to set a new, higher goal; if they fall short, they will be asked to try for the same goal again. If they improve sufficiently-or if their improvement stalls out-they will be asked if they want to focus on a new behavior.
Study NCT05776056 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Methylphenidate
Description: Methylphenidate 10mg will be taken twice daily.
Study NCT05776056 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: An inactive pill (placebo) will be taken twice daily.
Study NCT05709951 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional Exercises
Description: The patients were requested to perform these functional exercises for 4 days per week three times for 20 min (8 weeks).
Study NCT05709951 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core Stability Exercises
Description: The patients were requested to perform 4 core strengthening exercises for 4 days per week three times for 20 min (8 weeks)
Study NCT06219824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: premixed Bio-ceramic MTA
Description: pulpotomy treatment will be done and the premixed bioceramic MTA will be applied in the pulp chamber
Study NCT06219824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional MTA
Description: pulpotomy treatment will be done and powder and liquid MTA will be mixed and applied in the pulp chamber
Study NCT05092841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PXT3003
Description: Patients will be administered PXT3003 twice daily (bid) at 10mL.
Study NCT05092841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PXT3003 placebo
Description: Patients will be administered PXT3003 placebo twice daily (bid) at 10mL.
Study NCT06063616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki
Description: Level I Reiki was applied to 9 points and nearby areas for 30 minutes, three sessions a week, for a total of four weeks, in the first three hours of the HD treatment, by the researcher, who completed his second level training according to the Usui method, in line with the Reiki/Sham Reiki Application Protocol.
Study NCT06063616 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Reiki
Description: Sham Reiki was applied to 9 points and nearby areas in accordance with the Reiki/Sham Reiki Application Protocol, for a total of four weeks, three sessions per week, for 30 minutes, in the first three hours of the HD treatment, by two students who had not received Reiki training, and were given training on the application by the researcher.
Study NCT05838274 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol vs. Placebo beverage conditions
Description: Individuals will drink beverages containing alcohol. How they respond to a high vs. low dose will be compared.
Study NCT05838274 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Alcohol vs. Placebo beverage conditions
Description: Individuals will drink beverages containing alcohol. How they respond to a high vs. low dose will be compared.
Study NCT05043688 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiotherapy
Description: The study perform preoperative neoadjuvant therapy, surgery and postoperative adjuvant therapy on subjects. Preoperative neoadjuvant therapy includes 3 groups: iCamrelizumab combined with neoadjuvant chemotherapy; Camrelizumab combined with neoadjuvant radiochemotherapy, and neoadjuvant radiochemotherapy.
Study NCT05043688 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: The study perform preoperative neoadjuvant therapy, surgery and postoperative adjuvant therapy on subjects. Preoperative neoadjuvant therapy includes 3 groups: iCamrelizumab combined with neoadjuvant chemotherapy; Camrelizumab combined with neoadjuvant radiochemotherapy, and neoadjuvant radiochemotherapy.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core Behavioral Weight Loss Intervention
Description: All participants will receive a 10-week core behavioral weight loss treatment consisting of: self-monitoring weight, steps, and food intake; behavioral lessons; action plans; and tailored feedback. The intervention will be delivered remotely via email and digital tools (such as a smart scale, Fitbit activity tracker, and Fitbit app).
Study NCT06445153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention with clinical decision support system
Description: To this phase, patient data is automated and systematically analyzed in order to derive decision support based on current evidence and make it available to Digi-POD users (patients, relatives, nursing staff, doctors, other healthcare professionals).
Study NCT05486871 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic partial nephrectomy
Description: This is a prospective non- randomized controlled study of patients with RCC Who will be referred to urology department, Sohag university hospital. Our comparative study contained two groups according to tumor stage at preoperative contrast study:~Group \[A\] : 15 patients with T1 RCC (≤ 7 cm). Group \[B\] : 15 patients with T2a RCC (≤ 10 cm). the patients will be subjected to laparoscopic partial nephrectomy then will be followed up for two years for oncological and functional outcomes.
Study NCT06415747 — intervention group
Intervention type: OTHER
Intervention: Observational pain and motor function assessments, and also comorbidities assessments with x-ray.
Description: There was no intervention in our study, only observational and quantitative clinical evaluations.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Easier Step Goal
Description: Participants will receive an easier daily step goal.
Study NCT04747496 — intervention group
Intervention type: DRUG
Intervention: Edoxaban
Description: This is a non-interventional, observational study.
Study NCT05244889 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital CBT-I
Description: The digital CBT-I intervention (www.sleepio.com) consists of six weekly sessions of CBT-I delivered over the internet by an animated virtual therapist known as The Prof. The content includes behavioral (e.g. sleep restriction, stimulus control), cognitive (e.g. putting the day to rest, thought re-structuring, mindfulness) strategies, relaxation strategies (e.g., progressive muscle relaxation) and advice on lifestyle and bedroom factors (sleep hygiene). Although the sessions can be completed at the persons own pace, the shortest interval between individual sessions is 7 days, thus participants can complete the course in 6 weeks, or take as long as 12 weeks. As part of the SLEEPIO program, participants will be required to enter their sleep/wake patterns using electronic sleep diaries. There is no face-to-face contact throughout the intervention and all treatment sessions, support and reminders are provided through the online platform.
Study NCT05244889 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Hygiene Education
Description: Sleep Hygiene Education (SHE) has successfully been used as a control condition in other trials evaluating dCBT-I42. SHE does not have any therapeutic benefits for individuals with insomnia alone, but is often part of usual care. Consequently it is a credible alternative to dCBT-I. The sleep hygiene education will be provided on a website with access to information about lifestyle changes (e.g., reducing exercise in the evening, light snack before bedtime, reducing caffeine) and changes to the bedroom environment (e.g., dark room, comfortable mattress, optimal room temperature). As with the dCBT-I group, participants will not be required to make any changes to their usual care.
Study NCT05160584 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There is no interventional treatment component for participants with RRMM in this study.
Study NCT06500884 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Talquetamab
Description: Talquetamab will be administered subcutaneously.
Study NCT06500884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talquetamab
Description: Talquetamab will be administered subcutaneously.
Study NCT06500884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylaxis A
Description: Prophylaxis A will be administered orally.
Study NCT06500884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylaxis B
Description: Prophylaxis B will be administered orally.
Study NCT06500884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prophylaxis C
Description: Prophylaxis C will be administered orally.
Study NCT06045273 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Elders' Resilience Curriculum
Description: The Elders' Resilience Curriculum (ERC) is a culturally grounded, school-based program taught by White Mountain Apache Tribe (WMAT) Elders to youth. It is designed to prevent suicide ideation and behaviors for American Indian youth
Study NCT06518785 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low Intensity Focused Ultrasound
Description: An inhibitory LIFU protocol that allows suppression of neuronal activity in the basal ganglia and thalamus will be used.
Study NCT06518785 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Intensity Focused Ultrasound
Description: An inhibitory LIFU protocol that allows suppression of neuronal activity in the basal ganglia and thalamus will be used.
Study NCT06466109 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: social robot intervention
Description: In the first and second courses, the patients and their parents freely interact with the social robot PARO for 30 minutes.~In the third course, patients and their parents interact with PARO for 30 minutes using a worksheet that includes naming and recording characteristics of PARO.~In the last course, patients and their parents interact with PARO for 30 minutes using a worksheet that freely recorded their observations about PARO and say goodbye to it.
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Transvaginal ultrasound
Description: Intermittent transvaginal ultrasound throughout the cycle to monitor follicular growth
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serial serum LH, E2, P4
Description: Serial measurements of serum Luteinizing Hormone (LH), Estradiol (E2) and Progesterone (P4 )levels throughout the cycle to determine ovulation. LH-surge is identified when a rise of 180% above the previous level occurred and ovulation is confirmed with a decrease in E2 concentration, and a rise of progesterone level to ≥ 1.0 ng/ml (Irani et al., 2017).
Study NCT05969795 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Progesterone 100 Mg Vaginal Insert
Description: On day of ET procedure, to administer 200 mg of vaginal progesterone and increase to 300 mg/day from the day after the ET onwards until the pregnancy test. In case of an implantation, vaginal P4 will be continued until 7 weeks of pregnancy
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum P4 day of ET - Control Group
Description: Serum P4 will be drawn before starting LPS in form of vaginal progesterone on the day of ET procedure
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum P4 day of ET - Study Group
Description: Serum P4 will be drawn when study group participants are admitted to the clinic for the ET procedure.
Study NCT05969795 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Embryo transfer
Description: The procedure in which embryo is placed in the uterus.
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum hCG 10 days after ET
Description: Pregnancy will be confirmed / excluded by measurement of serum hCG 10 days after ET procedure and a level of > 15 IU will be regarded as positive result. The definitions of biochemical, ectopic, clinical and ongoing pregnancy follow the ICMART criteria (Zegers-Hochschild, 2006)
Study NCT05969795 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Serum P4 10 days after ET
Description: Serum P4 will be drawn on day 5 or day 6 after the ET procedure and together with the hCG 10 days after ET procedure
Study NCT05225935 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: image-guided VT ablation strategy
Description: Catheter ablation procedure performed as part of standard care, although with the addition of an image-based 3D heart model including detailed anatomy and primary ablation targets
Study NCT05225935 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional VT ablation strategy
Description: Catheter ablation will be performed using conventional mapping techniques to identify targets. The ablation strategy will be left to the local investigator's decision, based on the clinical scenario and operator's habits.
Study NCT04751929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Taken orally 2x daily
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harder Step Goal
Description: Participants will receive a more challenging daily step goal.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Easier Calorie Goal
Description: Participants will receive an easier daily calorie goal.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harder Calorie Goal
Description: Participants will receive a more challenging daily calorie goal.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Easier Eating Window Goal
Description: Participants will receive an easier daily eating window goal.
Study NCT05715242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harder Eating Window Goal
Description: Participants will receive a more challenging daily eating window goal, akin to time-restricted eating.